Cipla | CIPLA - Sales Revenues

Stock Price
1,202.00
Daily Change
1.10 0.09%
Monthly
-9.28%
Yearly
-16.09%
Q2 Forecast
1,166.41

Cipla reported INR75.18B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 110.08M 109.89M Dec/2025
Bio Path 0 0 Mar/2025
Brainstorm Cell Therapeutics 0 0 Mar/2025
Capricor Therapeutics USD 11.13M 8.87M Dec/2024
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Cipla INR 75.18B 710M Dec/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Esperion Therapeutics USD 168.45M 81.14M Dec/2025
Infinity Pharmaceuticals USD 583K 148K Jun/2023
Minerva Neurosciences USD 0 0 Sep/2024
Nektar Therapeutics USD 21.81M 2.32M Dec/2025
Sangamo BioSciences USD 356K 125K Jun/2024
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
TherapeuticsMD USD 234K 79K Jun/2024
UPL INR 123.61B 3.42B Dec/2025